Copyright Reports & Markets. All rights reserved.

Global Soft Skeletal Implant Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Soft Skeletal Implant Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Naturally Derived Biological Materials
    • 1.3.3 Synthetic Polymers
    • 1.3.4 Others
  • 1.4 Market Analysis by Manufacturing Process
    • 1.4.1 Overview: Global Soft Skeletal Implant Consumption Value by Manufacturing Process: 2021 Versus 2025 Versus 2032
    • 1.4.2 3D Printing Manufacturing
    • 1.4.3 Injection Molding
    • 1.4.4 Others
  • 1.5 Market Analysis by Degradation Period
    • 1.5.1 Overview: Global Soft Skeletal Implant Consumption Value by Degradation Period: 2021 Versus 2025 Versus 2032
    • 1.5.2 Rapid Degradation Type: Complete In-Vivo Degradation Period ≤ 12 Months
    • 1.5.3 Medium-Speed Degradation Type: Complete Degradation Period of 12–24 Months
    • 1.5.4 Slow Degradation Type: Complete Degradation Period Of 24–36 Months
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Soft Skeletal Implant Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Orthopedics
    • 1.6.3 Sports Medicine
    • 1.6.4 Dentistry
    • 1.6.5 Others
  • 1.7 Global Soft Skeletal Implant Market Size & Forecast
    • 1.7.1 Global Soft Skeletal Implant Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Soft Skeletal Implant Sales Quantity (2021-2032)
    • 1.7.3 Global Soft Skeletal Implant Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Stryker Corporation
    • 2.1.1 Stryker Corporation Details
    • 2.1.2 Stryker Corporation Major Business
    • 2.1.3 Stryker Corporation Soft Skeletal Implant Product and Services
    • 2.1.4 Stryker Corporation Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Stryker Corporation Recent Developments/Updates
  • 2.2 Enovis Corporation
    • 2.2.1 Enovis Corporation Details
    • 2.2.2 Enovis Corporation Major Business
    • 2.2.3 Enovis Corporation Soft Skeletal Implant Product and Services
    • 2.2.4 Enovis Corporation Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Enovis Corporation Recent Developments/Updates
  • 2.3 Smith & Nephew plc
    • 2.3.1 Smith & Nephew plc Details
    • 2.3.2 Smith & Nephew plc Major Business
    • 2.3.3 Smith & Nephew plc Soft Skeletal Implant Product and Services
    • 2.3.4 Smith & Nephew plc Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Smith & Nephew plc Recent Developments/Updates
  • 2.4 CONMED Corporation
    • 2.4.1 CONMED Corporation Details
    • 2.4.2 CONMED Corporation Major Business
    • 2.4.3 CONMED Corporation Soft Skeletal Implant Product and Services
    • 2.4.4 CONMED Corporation Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 CONMED Corporation Recent Developments/Updates
  • 2.5 KeriMedical SA
    • 2.5.1 KeriMedical SA Details
    • 2.5.2 KeriMedical SA Major Business
    • 2.5.3 KeriMedical SA Soft Skeletal Implant Product and Services
    • 2.5.4 KeriMedical SA Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 KeriMedical SA Recent Developments/Updates
  • 2.6 BRM Extremities S.r.l.
    • 2.6.1 BRM Extremities S.r.l. Details
    • 2.6.2 BRM Extremities S.r.l. Major Business
    • 2.6.3 BRM Extremities S.r.l. Soft Skeletal Implant Product and Services
    • 2.6.4 BRM Extremities S.r.l. Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BRM Extremities S.r.l. Recent Developments/Updates
  • 2.7 Osteotec Limited
    • 2.7.1 Osteotec Limited Details
    • 2.7.2 Osteotec Limited Major Business
    • 2.7.3 Osteotec Limited Soft Skeletal Implant Product and Services
    • 2.7.4 Osteotec Limited Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Osteotec Limited Recent Developments/Updates
  • 2.8 Fusion Orthopedics, LLC
    • 2.8.1 Fusion Orthopedics, LLC Details
    • 2.8.2 Fusion Orthopedics, LLC Major Business
    • 2.8.3 Fusion Orthopedics, LLC Soft Skeletal Implant Product and Services
    • 2.8.4 Fusion Orthopedics, LLC Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Fusion Orthopedics, LLC Recent Developments/Updates
  • 2.9 Weigao Orthopedics
    • 2.9.1 Weigao Orthopedics Details
    • 2.9.2 Weigao Orthopedics Major Business
    • 2.9.3 Weigao Orthopedics Soft Skeletal Implant Product and Services
    • 2.9.4 Weigao Orthopedics Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Weigao Orthopedics Recent Developments/Updates
  • 2.10 MicroPort Orthopedics
    • 2.10.1 MicroPort Orthopedics Details
    • 2.10.2 MicroPort Orthopedics Major Business
    • 2.10.3 MicroPort Orthopedics Soft Skeletal Implant Product and Services
    • 2.10.4 MicroPort Orthopedics Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MicroPort Orthopedics Recent Developments/Updates
  • 2.11 Chunli Medical
    • 2.11.1 Chunli Medical Details
    • 2.11.2 Chunli Medical Major Business
    • 2.11.3 Chunli Medical Soft Skeletal Implant Product and Services
    • 2.11.4 Chunli Medical Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Chunli Medical Recent Developments/Updates
  • 2.12 Double Medical
    • 2.12.1 Double Medical Details
    • 2.12.2 Double Medical Major Business
    • 2.12.3 Double Medical Soft Skeletal Implant Product and Services
    • 2.12.4 Double Medical Soft Skeletal Implant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Double Medical Recent Developments/Updates

3 Competitive Environment: Soft Skeletal Implant by Manufacturer

  • 3.1 Global Soft Skeletal Implant Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Soft Skeletal Implant Revenue by Manufacturer (2021-2026)
  • 3.3 Global Soft Skeletal Implant Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Soft Skeletal Implant by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Soft Skeletal Implant Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Soft Skeletal Implant Manufacturer Market Share in 2025
  • 3.5 Soft Skeletal Implant Market: Overall Company Footprint Analysis
    • 3.5.1 Soft Skeletal Implant Market: Region Footprint
    • 3.5.2 Soft Skeletal Implant Market: Company Product Type Footprint
    • 3.5.3 Soft Skeletal Implant Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Soft Skeletal Implant Market Size by Region
    • 4.1.1 Global Soft Skeletal Implant Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Soft Skeletal Implant Consumption Value by Region (2021-2032)
    • 4.1.3 Global Soft Skeletal Implant Average Price by Region (2021-2032)
  • 4.2 North America Soft Skeletal Implant Consumption Value (2021-2032)
  • 4.3 Europe Soft Skeletal Implant Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Soft Skeletal Implant Consumption Value (2021-2032)
  • 4.5 South America Soft Skeletal Implant Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Soft Skeletal Implant Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Soft Skeletal Implant Sales Quantity by Type (2021-2032)
  • 5.2 Global Soft Skeletal Implant Consumption Value by Type (2021-2032)
  • 5.3 Global Soft Skeletal Implant Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Soft Skeletal Implant Sales Quantity by Application (2021-2032)
  • 6.2 Global Soft Skeletal Implant Consumption Value by Application (2021-2032)
  • 6.3 Global Soft Skeletal Implant Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Soft Skeletal Implant Sales Quantity by Type (2021-2032)
  • 7.2 North America Soft Skeletal Implant Sales Quantity by Application (2021-2032)
  • 7.3 North America Soft Skeletal Implant Market Size by Country
    • 7.3.1 North America Soft Skeletal Implant Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Soft Skeletal Implant Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Soft Skeletal Implant Sales Quantity by Type (2021-2032)
  • 8.2 Europe Soft Skeletal Implant Sales Quantity by Application (2021-2032)
  • 8.3 Europe Soft Skeletal Implant Market Size by Country
    • 8.3.1 Europe Soft Skeletal Implant Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Soft Skeletal Implant Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Soft Skeletal Implant Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Soft Skeletal Implant Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Soft Skeletal Implant Market Size by Region
    • 9.3.1 Asia-Pacific Soft Skeletal Implant Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Soft Skeletal Implant Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Soft Skeletal Implant Sales Quantity by Type (2021-2032)
  • 10.2 South America Soft Skeletal Implant Sales Quantity by Application (2021-2032)
  • 10.3 South America Soft Skeletal Implant Market Size by Country
    • 10.3.1 South America Soft Skeletal Implant Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Soft Skeletal Implant Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Soft Skeletal Implant Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Soft Skeletal Implant Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Soft Skeletal Implant Market Size by Country
    • 11.3.1 Middle East & Africa Soft Skeletal Implant Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Soft Skeletal Implant Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Soft Skeletal Implant Market Drivers
  • 12.2 Soft Skeletal Implant Market Restraints
  • 12.3 Soft Skeletal Implant Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Soft Skeletal Implant and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Soft Skeletal Implant
  • 13.3 Soft Skeletal Implant Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Soft Skeletal Implant Typical Distributors
  • 14.3 Soft Skeletal Implant Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Soft Skeletal Implant market size was valued at US$ 80.93 million in 2025 and is forecast to a readjusted size of US$ 112 million by 2032 with a CAGR of 4.6% during review period.
    In 2025, global Soft Skeletal Implant production reached approximately 70,223 Units.The average price is approximately $1,120.Soft Skeletal Implant are long-term implantable medical devices used to reconstruct or replace small joints of the fingers, thumb, and toes. They are generally manufactured from implant-grade silicone elastomer selected for biocompatibility, flexibility, and resistance to repeated bending.
    Soft Skeletal Implant constitute a mature but highly specialised segment of the orthopaedic implant industry. The appropriate market boundary is substantially narrower than the literal expression “Soft Skeletal Implant,” which appeared in certain historical product names but is not a consistently used contemporary category. The market is centred on long-term implantable silicone elastomer prostheses and dynamic spacers for the metacarpophalangeal, proximal interphalangeal, selected thumb, and metatarsophalangeal joints. Their clinical purpose is generally to preserve joint spacing, alignment, and a functional range of motion rather than to reproduce the complete surface mechanics of a natural joint. Most products use a one-piece, double-stemmed flexible structure, while more recent configurations incorporate pre-flexed hinges, modified stem geometries, broader size ranges, or optional titanium grommets. Innovation is therefore predominantly incremental, focusing on fatigue resistance, implant positioning, protection at the bone–implant interface, and simplified instrumentation. In the United States, constrained polymer finger-joint prostheses are regulated as Class II devices, while European suppliers are increasingly influenced by Medical Device Regulation recertification, clinical-evidence requirements, and post-market surveillance. These regulatory conditions favour suppliers with established technical files and long clinical histories, but they can also create opportunities for specialist manufacturers capable of updating legacy product systems.
    The global supply base is concentrated in North America and Western Europe and is much smaller than broad orthopaedic-device databases may suggest. Our research identifies approximately eight current independent economic groups with sufficiently strong official evidence of finished silicone small-joint implants. The competitive structure consists of diversified orthopaedic groups, specialist hand and wrist companies, and focused foot-and-ankle suppliers. Stryker, Enovis, Smith & Nephew, and CONMED benefit from broader hospital access, regulatory infrastructure, surgical instrumentation, and established surgeon relationships. KeriMedical, Osteotec, BRM Extremities, and Fusion Orthopedics compete through specialist product design, anatomical focus, regional distribution partnerships, and responsiveness to small-volume indications. Corporate transactions have materially reshaped the apparent supplier list. Enovis acquired selected finger-arthroplasty product lines from Stryker, CONMED acquired In2Bones, and the Ascension and Integra silicone product lineage is now associated with Smith & Nephew. BRM-manufactured products are also sold through distributors such as Fuse Medical and BioPro. Consequently, counting every historical brand, registration holder, or distributor as a separate manufacturer would materially overstate the number of suppliers and could duplicate revenue. The extended longlist is larger because it also includes implant-grade silicone producers and contract manufacturers, but these upstream companies are not included in finished-implant market revenue unless there is evidence of direct product sales.
    Demand is expected to expand gradually rather than accelerate rapidly. Ageing populations, chronic inflammatory arthritis, degenerative small-joint disease, deformity correction, and revision of older implants provide a recurring clinical base. The hand segment is led by MCP and PIP reconstruction, while the foot segment is concentrated in first and lesser MTP procedures. Implant-unit demand can exceed recorded procedure volumes because several joints may be replaced during one operation, particularly in patients with rheumatoid or inflammatory disease. Nevertheless, the addressable population remains small compared with hip and knee arthroplasty, and alternative procedures impose a meaningful ceiling on growth. Arthrodesis remains an important option for advanced first-MTP disease, while pyrocarbon, metal–polymer surface-replacement systems, and non-implant surgical treatments compete in selected hand indications. Future competitive differentiation is likely to depend on fatigue performance, implant geometry, sizing breadth, instrument simplicity, traceability, regional registrations, and surgeon education rather than a wholesale change in the underlying silicone-spacer concept.
    This report is a detailed and comprehensive analysis for global Soft Skeletal Implant market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Soft Skeletal Implant market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Soft Skeletal Implant market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Soft Skeletal Implant market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Soft Skeletal Implant market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Soft Skeletal Implant
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Soft Skeletal Implant market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Enovis Corporation, Smith & Nephew plc, CONMED Corporation, KeriMedical SA, BRM Extremities S.r.l., Osteotec Limited, Fusion Orthopedics, LLC, Weigao Orthopedics, MicroPort Orthopedics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Soft Skeletal Implant market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Naturally Derived Biological Materials
    Synthetic Polymers
    Others
    Market segment by Manufacturing Process
    3D Printing Manufacturing
    Injection Molding
    Others
    Market segment by Degradation Period
    Rapid Degradation Type: Complete In-Vivo Degradation Period ≤ 12 Months
    Medium-Speed Degradation Type: Complete Degradation Period of 12–24 Months
    Slow Degradation Type: Complete Degradation Period Of 24–36 Months
    Market segment by Application
    Orthopedics
    Sports Medicine
    Dentistry
    Others
    Major players covered
    Stryker Corporation
    Enovis Corporation
    Smith & Nephew plc
    CONMED Corporation
    KeriMedical SA
    BRM Extremities S.r.l.
    Osteotec Limited
    Fusion Orthopedics, LLC
    Weigao Orthopedics
    MicroPort Orthopedics
    Chunli Medical
    Double Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Soft Skeletal Implant product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Soft Skeletal Implant, with price, sales quantity, revenue, and global market share of Soft Skeletal Implant from 2021 to 2026.
    Chapter 3, the Soft Skeletal Implant competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Soft Skeletal Implant breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Soft Skeletal Implant market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Soft Skeletal Implant.
    Chapter 14 and 15, to describe Soft Skeletal Implant sales channel, distributors, customers, research findings and conclusion.

    Buy now